Takeda Pharmaceutical Buys PE-Backed Nycomed for $13.6B

Japan’s largest drugmaker, Takeda Pharmaceutical Co., will pay $13.6 billion to buy private equity backed rival Nycomed, Reuters reported. Zurich-based Nycomed is majority owned by four private equity firms, led by Nordic Capital with 41%. Credit Suisse's DLJ Merchant Banking has 25.6%, Coller International Partners 9.7% and Avista 8.9%.

DealsNorth AmericaUSBriefs